Preterm birth and intrapartum related complications account for a substantial amount of
mortality and morbidity in the neonatal period despite significant advancements in neonatal …

Extreme preterm birth disrupts late lung development and puts newborns at risk of
developing chronic lung disease, known as bronchopulmonary dysplasia (BPD). BPD can …

Despite advances in neonatal care, the incidence of Bronchopulmonary Dysplasia (BPD)
remains high among extreme preterm infants. The pathogenesis of BPD is multifactorial, with …

Oxidative stress and fibrosis are important stress responses that characterize
bronchopulmonary dysplasia (BPD), a disease for which only a therapy but not a cure has …

Background Alveolar epithelial cell (AEC) ferroptosis contributes to the progression of acute
lung injury (ALI). Esketamine (ESK) is a new clinical sedative, anesthetic, and analgesic …

Background Despite advances in neonatal care, the incidence of Bronchopulmonary
Dysplasia (BPD) remains high among preterm infants. Human induced pluripotent stem cells …

Lung diseases are a main cause of mortality and morbidity in neonates. Despite major
breakthroughs, therapies remain supportive and, in some instances, contribute to lung …

Premature birth is a leading cause of childhood morbidity and mortality and often followed
by an arrest of postnatal lung development called bronchopulmonary dysplasia. Therapies …

Bronchopulmonary dysplasia (BPD) is a multifactorial disease occurring as a consequence
of premature birth, as well as antenatal and postnatal injury to the developing lung. BPD …

Lung and brain injury that occurs during the perinatal period leads to lifelong disability and
is often driven and/or exacerbated by inflammation. Human amniotic epithelial cells (hAEC) …